Jerel Banks is Chairman and Chief Executive Officer of Benitec Biopharma Inc. (BNTC). The company reported total compensation of $25,865,036 for fiscal year 2025.
| Salary | $661,100 |
|---|---|
| Bonus | $366,850 |
| Stock awards | $0 |
| Option awards | $24,795,540 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $41,546 |
| Total | $25,865,036 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Benitec Biopharma Inc. filed October 14, 2025, accession 0001193125-25-239131.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jerel Banks this page | Chairman and Chief Executive Officer | $25,865,036 |
| Megan Boston | Chief Financial Officer, Secretary | $8,599,293 |
| Sophie Mukadam | Chief Operating Officer | $3,775,393 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Benitec Biopharma Inc. compensation brief.
Jerel Banks's compensation sits inside Benitec Biopharma Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.